ASGCT 28th Annual Meeting 2025
Ernest N. Morial Convention Center, New Orleans, Louisiana
May 13, 2025 - May 17, 2025The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting highlights the latest advancements and technologies in cell and gene therapy (CGT) development. Join us at booth #2018 and check out our resources below to learn about our microbial controls and cell lines that support CGT development and quality and safety testing.
Want to speak to one of ATCC’s representatives about a product or service? Contact us so we can discuss your needs.
Explore our products for CGT development and safety testing
Streamline microbial QC testing with MicroQuant™
Using our innovative cryopreservation technology we have developed our best-in-class microbial controls strains in the form of stable, rapidly rehydrating pellets that deliver consistent quantitation and accurate, reproducible results—addressing the key challenges faced by microbial testing laboratories.
Explore MicroQuant™ strainsThawReady™ Assay Ready Cells
Cell-based assays have lengthy timelines due to the requirement of cell expansion processes to get a synchronized cell stock. To speed your timelines while providing you with the consistency you need, ATCC developed ThawReady™ cells. ATCC ThawReady™ products will streamline your workflows by months, allowing you to focus on advancing drug discovery and development.
Explore ThawReady™ Assay Ready CellsBrowse our featured resources
Brochure
CAR-T Target Luciferase Reporter Cells
ATCC generated CAR-T Target Luciferase Reporter Cells lines that have high endogenous expression of clinically relevant cell surface tumor antigens, such as CD19, CD20, and HER2. These new immuno-oncology tools are comprised of both solid and liquid tumor cell lines that exhibit sensitive and stable luciferase reporter expression.
MoreMicroQuant™ - Precision in every pellet, trust in every test
Learn about our precisely quantitated microbial reference materials for streamlining microbial quality control testing.
More
Brochure
Viral Reference Materials
When evaluating a novel viral-vector-based gene therapy, accurately determining dose and potency is essential for patient safety. ATCC supports this need by providing internationally accepted viral reference materials that enable the standardization of quantification techniques between organizations.
MoreContact us today
Your ATCC sales representative stands ready to discuss your research needs and provide you with personalized care. Please complete our form to let us know how we can help, and we will start working on your needs right away.
